Paternal lymphocyte immunization refers to the use of paternal lymphocyte immunotherapy or lymphocytic sensitization treatment in this context. Recurrent pregnancy and abortion are some of the conditions where this approach has been applied for treatment. This therapeutic intervention is based on the hypothesis that during a reproductive loss, a certain role may belong to the materno-fetal immune interaction.
When a couple is faced with multiple losses, failed embryo implantations, or even unsuccessful fertilizing techniques, they tend to search for explanations and potential solutions in immunological therapies. Yet, it is crucial for one to get to know what paternal lymphocyte immunization is, what the presumed mechanism could be, and, in particular, what the currently available scientific evidence and reproductive guidelines indicate about its use.
What Is Paternal Lymphocyte Immunization?
Paternal lymphocyte immunization is a form of immune therapy that uses lymphocytes, which is often shortly known as LIT.
Lymphocytes are a kind of white blood cell that plays a role in immune defense. Traditionally, the male partner prepares lymphocytes and gives them to his female partner before pregnancy in the paternal lymphocyte immunization method.
Through this intervention, many believe the pre-conceptual phase maternal immune response could either change or be directed.
Researchers have mostly studied paternal lymphocyte immunization in patients with multiple pregnancy losses, particularly if these patients underwent traditional investigations, and no definite reasons emerged for such miscarriage recurrence.
How Is Paternal Lymphocyte Immunotherapy Thought to Work?
The concept of paternal lymphocyte immunization grew from the understanding that pregnancy is the result of a very complicated relationship between a mother’s immune system and cells carrying the father’s genes.
Originally, some hypotheses considered that some women who had recurrent pregnancy loss were having a wrong immune response to their partner’s antigens. The main idea of research work at that time was that if the male partner’s lymphocytes were introduced to a woman before she got pregnant, this would prompt her immune system to make so-called protective or blocking antibodies.
This could provide a pregnancy with an easier and safer immune condition if there are these blocking antibodies.
Still, no solid mechanism behind the proposed process has been identified yet; mostly that of recurrent miscarriage is not well explained by such a mechanism at this stage. Because of this, if anything, the scientific rationale for routine use of lymphocyte immunization as a type of treatment is weak, mainly because the function of anti-paternal or blocking antibodies is still not well understood scientifically.
Why Has Paternal Lymphocyte Immunization Been Used?
Paternal lymphocyte immunization has been suggested in the past for cases like:
Recurrent pregnancy loss
Repeated miscarriage with no apparent cause
Unexplained recurrent miscarriage
Previous failed pregnancies
Selected cases of repeated implantation failure
The psychological devastation caused by repeated miscarriage can be huge. Couples who have been through several losses might naturally be driven to look for other tests and treatments when the standard investigations fail to pinpoint the issue.
But the existence of a treatment option doesn’t automatically imply that the treatment’s efficacy has been validated to a high degree.
Does Paternal Lymphocyte Immunization Improve Pregnancy Outcomes?
What are the major reasons for miscarriage?
Early experiments showed great promise in lymphocyte immunization therapy, and several trials actually claimed that this therapy was beneficial in selected cases of female infertility. Yet, subsequent meta-analyses and systematic reviews failed to substantiate any major improvements in live birth rates.
A joint assessment by the European Society for Human Reproduction and Embryology ESHRE)and other authorities found that there is insufficient evidence to recommend the use of lymphocyte immunization therapy to treat unexplained recurrent pregnancy loss. Also highlighted was the absence of demonstration of any significant clinical benefit and potential harms related to this therapy.
Like that, the American Society for Reproductive Medicine does not recommend the routine use of immune testing and treatment for recurrent pregnancy loss. Its guidance also states that lymphocyte immunization therapy has not been useful when it was given empirically to unexplained recurrent pregnancy loss.
In this case, paternal lymphocyte immunization should not be promoted as an effective treatment for recurrent miscarriage.
Paternal Lymphocyte Immunization and Recurrent Pregnancy Loss
When it comes to recurrent pregnancy loss, multiple layers of medical complexity are involved. It’s understood that repeated losses probably warrant a fertility workup including a pregnancy loss evaluation, based on the definitions currently used mainly by the major reproductive medicine organisations.
These areas of investigation could involve:
parental or foetal genetic factors
uterus or womb malformation
fertility disorder due to antiphospholipid syndrome
a hormonal or metabolic disorder if clinically relevant
factors related to lifestyles
issues in a man’s fertility
independent medical conditions
Still, in most affected couples, no specific cause is detected. The condition is called unexplained recurrent pregnancy loss.
The mere fact that there is a cause which has remained unexplained doesn’t indicate by itself that the immune system is to blame. Also, even if it is supposed to be the immune system, it does not necessarily mean an immune therapy for the couple, such as immunotherapy with paternal lymphocytes, will actually help achieve a healthy pregnancy.
Are There Risks Associated with Lymphocyte Immunization Therapy?
Safety is an important matter, as paternal LTI (Lymphocyte Immunotherapy) entails the person’s exposure to an “alien” (someone else’s) blood cells.
Some concern was expressed about the adverse effects that can occur from allogeneic lymphocytes. It involves immunological complications and transmitting infectious agents if proper screenings and safety measures are not implemented.
Long-term safety of lymphocyte immunotherapy research is also very scarce.
This is why choosing immune-based fertility treatments calls for an evidence-based discussion session that also covers risks, regulatory issues, and the comparison with alternative methods.
Paternal Lymphocyte Immunization and IVF
It is not unusual for some patients undergoing IVF treatment to inquire whether a male cell immunization, i.e., paternal lymphocyte immunization, can enhance implantation or help the IVF to be successful.
Implantation is a rather intricate procedure, and it depends on more than just one thing; this includes the quality of the embryo or factors like endometrial receptivity, uterine health, embryological health, and chromosomal factors. It is also related to the interplay of biological factors.
That means we should not immediately blame repeating IVF cycles after failing on immune deficiency only.
A fertility doctor can review factors like embryo development, embryo quality, genetic testing (when it is clinically advised), embryo transfer method, how the uterus looks, and what the patient experienced during all the previous treatment cycles.
At the moment, there is no strong evidence suggesting using paternal lymphocyte immunization as a regular IVF procedure or the use of it as a reliable technique to facilitate embryo adhesion.
Why Evidence-Based Fertility Care Matters
Fertility treatment is often a challenge to both emotional and financial well-being. Couples may be subjected to many tests, supplements, and procedures that are supposed to help increase the odds of successfully getting pregnant.
Making decisions is also a tricky affair. Sometimes, a combination of treatment approaches can be beneficial; sometimes it’s the opposite. So, one should focus on the evidence supporting the benefits of the specific investigations and treatments for the individual’s diagnosis.
A tailor-made fertility plan may be made according to factors:
the woman’s age
medical history
The woman’s number & time of miscarriages
Her fertility record
Embryo development
He’s male partner’s assessment
Woman’s uterine status
Genedis
List of medical conditions
At the same time, the patient should not be overburdened with unnecessary information. This is in particular when the exact reason for recurrent miscarriage is known. Because of this, if the cause remains a medical mystery, then the doctor should be upfront about what they can and cannot do in the matter.
What Should Couples with Recurrent Miscarriage Do?
Couples who have undergone multiple instances of pregnancy loss should seek a review of their case by someone with expertise in this type of fertility specialist, or more precisely, by a specialist in recurrent pregnancy loss.
A thorough investigation is very important, and doctors can likely diagnose treatable causes and provide the correct type and time of care before you get pregnant again.
On the emotional side, you also have to look after it. Many women find that repeated miscarriages not only affect a couple’s relationship but can also cause a great deal of psychological trauma, and the support of a very caring and kind doctor is very much required while undergoing fertility treatments.
If you are at Zemya IVF & Fertility Clinics, you and your spouse can come to us for a private and personalized consultation session where we shall explain what we think of your fertility issues. We shall go through with your history of reproduction and discuss with you the kinds of treatment that might come to your aid. As a good diagnosis is usually the only way to determine a correct mode and timing of treatment, and all decisions should be made on solid data, you and your partner will need your doctor’s medical opinion.
The Bottom Line
Paternal lymphocyte immunization is a treatment method based on the immune system that was studied for recurrent pregnancy loss and multiple gestational failures. This modality relies on the use of the male partner’s lymphocytes to influence the maternal immune system before pregnancy.
Although there was quite a bit of enthusiasm in the reproductive medicine community about the therapeutic option, nowadays available data do not show that this approach would give any real advantage for women who undergo repeated pregnancy loss from an unknown cause. The key fertility societies are still not listing lymphocyte immunization as a standard treatment in their guidelines.
If couples are experiencing repeated early pregnancy loss or they are not responding to their fertility treatments, then the first step should be to get a full and detailed workup that will reveal if there are any causative factors so that a well-based and individualised treatment plan can be designed.
Besides the performance of a treatment, the underlying rationale of a therapy is another essential factor to know. In light of these points, the takeaway is that women suffering from recurrent pregnancy loss need to be given proper information, realistic expectations, and treatment strategies based on the best evidence available.
